Ann: Breast Cancer Clinical Trial Program Initiated, page-51

The MSA with George Clinical has quite of list of deliverables...

"The first stage of the signed Master Service Agreement (MSA) between Race Oncology and George Clinical has the following key deliverables:

• Establish, support and manage an Australian Clinical Advisory Board (CAB) of Key Opinion Leaders (KOL) in breast cancer clinical research.
• Select suitable Principle Investigators.
• Select qualified trial sites.Develop a full clinical protocol under the supervision of the CAB.
• Statistical analysis to ensure a robust trial design.
• Detailed trial costs and timelines.
• Report on the practicability of the trial and any possible regulatory hurdles.

The MSA will start immediately with an estimated completion time of 13 weeks."

1. Is the expectation that the upcoming update in the next couple of weeks that all of the above will be complete? or should we expect some of the above to be reported on and others still in progress?
2. Any interpretation of what "first stage" implies... i.e. assume then perhaps a second stage scope of works might be following a similar path for pillar 1?